Rigel Pharmaceuticals
Commercializes specialty treatments for a blood disorder, a leukemia, and RET-fusion cancers in the US.
$46.15
After-hours close−0.35 (−0.75%)
At close$46.50(−0.77%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 89.44%16.55M sharesInsiders 3.34%617.1K sharesOther 7.22%1.34M shares
Shares outstanding 18.50M · Float 17.87M · 96.6% free float
Institutions13F, as of Jun 30, 2026
161 holders · 16.55M shares · 34 new positions · 89 increased · 54 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 1.94M | 10.48% | +170.9K | Aug 7, 2026 |
| Soleus Capital Management, L.P. | 1.84M | 9.96% | +1.83M | Aug 11, 2026 |
| Armistice Capital, LLC | 1.67M | 9.04% | +392.0K | Aug 14, 2026 |
| State Street Corp | 1.04M | 5.62% | −80.2K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 785.1K | 4.24% | +20.9K | Aug 13, 2026 |
| American Century Companies Inc | 741.7K | 4.01% | +197.3K | Aug 12, 2026 |
| LSV Asset Management | 721.7K | 3.90% | +120.2K | Aug 6, 2026 |
| Acadian Asset Management LLC | 591.7K | 3.20% | −74.7K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.70% | 1.38M | 13G | Apr 17, 2025 ↗ |
| Armistice Capital, LLC | 6.93% | 1.28M | 13G | May 15, 2026 ↗ |
| State Street Corporation | 6.00% | 1.09M | 13G | Feb 9, 2026 ↗ |
| Soleus Capital Master Fund, L.P. | 5.20% | 968.1K | 13G | May 7, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Raul R. Rodriguez | director, officer: CEO, President | 279.6K | 1.51% | Jun 3, 2026 |
| Dean L. Schorno | officer: EVP & Chief Financial Officer | 77.5K | 0.42% | Jun 3, 2026 |
| David A. Santos | officer: EVP, Chief Commercial Officer | 62.0K | 0.34% | Jun 3, 2026 |
| Raymond J. Furey | officer: EVP, GC, CCO & Corp Sec | 50.9K | 0.28% | Jun 3, 2026 |
| Alison L. Hannah | officer: EVP, Chief Medical Officer | 35.0K | 0.19% | Jul 10, 2026 |
| Lisa Rojkjaer | officer: EVP, Chief Medical Officer | 34.0K | 0.18% | Jun 3, 2026 |
| Walter H. Moos | director | 18.5K | 0.10% | May 19, 2026 |
| Anthony Gregg Lapointe | director | 18.3K | 0.10% | May 19, 2026 |
| Jane Wasman | director | 18.3K | 0.10% | May 19, 2026 |
| Kamil Ali-Jackson | director | 10.1K | 0.05% | Jun 24, 2026 |
6 ten-percent owners hold 914.1K shares by Form 4, outside the officers-and-directors figure above · 15 people have not refiled in the last 18 months (84.7K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 22, 2026 | Kamil Ali-Jacksondirector | Sale | 2,500 | $35.00 | 10,125 |
| May 26, 2026 | Kamil Ali-Jacksondirector | Sale | 2,500 | $29.17 | 12,625 |
| Feb 20, 2026 | Walter H. Moosdirector | Sale | 4,000 | $36.36 | 12,722 |
CongressHouse and Senate disclosures
Not reported.